Heart Transplant: A Never-Ending Story

Despite ongoing advancements in the field of heart failure, heart transplantation remains the definitive treatment for patients with advanced heart failure. Decades of research, surgical innovation, and progress in transplant immunology have enabled the overcoming of persistent challenges associated with this complex procedure. Since the initial preclinical experiments involving heart transplants in canines and primates, the process has been profoundly transformed through the development of the bioptome for endomyocardial biopsies and the introduction of immunosuppressive therapies. More recently, improvements in the preservation and transportation of donor hearts, as well as the utilization of cell-free DNA for evaluating graft rejection, are laying the groundwork for further advancements in non-invasive rejection diagnosis and the expansion of the donor pool.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine
Published
2025-09-26
DOI
https://doi.org/10.3390/jcm14196805
Primary Topic
Transplantation: Methods and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Heart Transplant: A Never-Ending Story

Rita Gravino, Daniele Masarone, M. Kittleson, Cristiano Amarelli et al.
Journal of Clinical Medicine
Transplantation: Methods and Outcomes
article

Heart Transplant: A Never-Ending Story

Rita Gravino, Daniele Masarone, M. Kittleson, Cristiano Amarelli, Luigi Falco, Claudio Marra, Emilio Di Lorenzo, Angelo Caiazzo, Dario Catapano, Pierino Di Silverio
article en

Abstract

Despite ongoing advancements in the field of heart failure, heart transplantation remains the definitive treatment for patients with advanced heart failure. Decades of research, surgical innovation, and progress in transplant immunology have enabled the overcoming of persistent challenges associated with this complex procedure. Since the initial preclinical experiments involving heart transplants in canines and primates, the process has been profoundly transformed through the development of the bioptome for endomyocardial biopsies and the introduction of immunosuppressive therapies. More recently, improvements in the preservation and transportation of donor hearts, as well as the utilization of cell-free DNA for evaluating graft rejection, are laying the groundwork for further advancements in non-invasive rejection diagnosis and the expansion of the donor pool.

Journal of Clinical MedicineVol. 14(19)
Cedars-Sinai Medical Center (US), Ospedale Monaldi (IT), Cedars-Sinai Smidt Heart Institute (US)
Openalex Percentile: Top 54%
Transplantation: Methods and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.